Global Artificial Intelligence in Genomics market size in 2021 was USD 471 Million, market value to grow to USD 18,213 Million by 2030 at 50.2% CAGR as per Acumen Research and Consulting
Artificial Intelligence (AI) has revolutionized the field of genomics by enabling researchers to analyze and interpret vast amounts of genetic data. In this article, we will discuss the market overview, diverse application, market segmentation, market dynamics, market challenges, regional overview, and the key players in the AI in Genomics market.
Market Overview with Diverse Application
The application of AI in genomics has transformed the way researchers study genetic data. AI algorithms can analyze and interpret vast amounts of data, identify patterns, and provide insights into complex biological processes. AI is used in genomics research for various applications, including disease diagnosis, drug discovery, personalized medicine, and agriculture.
Market Segmentation
The AI in Genomics market can be segmented into tools, applications, and region. By tools, the market can be classified into machine learning, natural language processing, and other AI tools. By application, the market can be segmented into diagnostics, drug discovery, personalized medicine, and agriculture. By region, the market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World.
Download Free Artificial Intelligence in Genomics Market Sample report here
https://www.acumenresearchandconsulting.com/request-sample/2999
Market Dynamics
The growth of the AI in Genomics market is driven by several factors. First, the increasing demand for personalized medicine and precision medicine is a significant driver. Second, the growth in genomics research and the availability of vast amounts of genetic data are fueling the demand for AI in genomics. Third, the increasing adoption of AI in drug discovery and diagnostics is also contributing to the growth of the market.
Market Challenges
Despite the benefits of AI in genomics, there are some challenges that need to be addressed. First, the lack of standardization and interoperability of genetic data is a significant challenge. Second, the high cost of implementing AI tools in genomics research is a major challenge. Third, the ethical and legal implications of using AI in genomics research need to be addressed.
Market Regional Overview
North America is expected to dominate the AI in Genomics market during the forecast period, owing to the increasing adoption of AI in drug discovery and personalized medicine. Europe and Asia Pacific are also significant markets, owing to the growth in genomics research and the increasing demand for personalized medicine.
Market Players
The following are some of the key players in the AI in Genomics market:
Google LLC (Alphabet Inc.)IBM CorporationIntel CorporationNVIDIAMicrosoftIllumina.QIAGEN N.V.Niramai Health Analytix Pvt. Ltd.Freenome Holdings, Inc.FDNA Inc.Fabric Genomics, Inc.Diploid NV.
Buy the premium market research report here.
https://www.acumenresearchandconsulting.com/buy-now/0/2999
Find more such market research reports on our website or contact us directly
Write to us at [email protected]
Call us on +918983225533
or +13474743864
According to the new market research report Artificial Intelligence In Genomics Market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market.
However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.
Based on offering, the Artificial Intelligence In Genomics Market is segmented into software and services.
The software and services segment accounted for largest share of the global AI in genomics market in 2019.
Software is needed to generate new insights from large-scale datasets and help understand genomic variations, thus enhancing the search for disease-causing variants and reducing clinical analysis times.
The benefits offered by AI in software are driving its adoption among end users.Based on functionality, the AI in genomics market is segmented into genome sequencing, gene editing, clinical workflows, and predictive genetic testing & preventive medicine.
The report titled as Artificial Intelligence (AI) In Genomics Market Size has been recently added by Absolute Markets Insights which provide readers with a stronger and effective business outlook.
The data also presents penetrative insights into several industry attributes such as trends, policies, and clients operating in widespread industrial regions.
The qualitative and quantitative analysis techniques have also been used by analysts to provide an accurate overview of global business owners and industry trends.
Among other salient features of the report, the study also incorporates client’s demands as well as insinuates future progress of the market across global regions.The analysts have distributed the global Artificial Intelligence (AI) In Genomics Market Size into several regions such as North America, Latin America, Asia-Pacific, Africa, and India for a detailed market study.
The financial aspects of the business are also meticulously studied referring to several attributes such as price, profit margins and sales by regions during the forecast period (2021-2030).Browse the Full Information of this report: https://www.absolutemarketsinsights.com/reports/Artificial-Intelligence-AI-in-Genomics-Market-2021---2029-896The report also includes information on significant market players in order to deliver penetrative insights into the businesses with regards to successful strategies of top-notch companies.
Moreover, the report offers comprehensive information of several traders by presenting accurate facts and figures of market shares.
